Tuesday, March 31, 2020

3M ramping up N95 respirators to reach 50M per month in June

›
3M (NYSE: MMM ) says it expects to produce N95 respirators at a rate of 50M per month in June, a 40% increase from current levels . The ...

FDA rallies troops to accelerate development of COVID-19 treatments

›
The FDA announces its Coronavirus Treatment Acceleration Program that, it says, leverages every tool at its disposal (e.g., cutting red...

InflaRx doses first COVID-19 with IFX-1; shares up 24% after hours

›
InflaRx N.V. (NASDAQ: IFRX ) announces that dosing is underway in a randomized clinical trial evaluating IFX-1 in patients with severe CO...

Fujifilm ramps up production of flu drug Avigan as possible COVID-19 treatment

›
Fujifilm says it is prepared to offer Avigan to any country that wants to try it as a potential treatment for COVID-19. But even as it h...

Gilead CEO: remdesivir to be ‘affordable,’ but it could still rake in revenue

›
Will Gilead Sciences make a fortune out of remdesivir if the antiviral proves effective against the novel coronavirus? Maybe—or maybe not...

China APIs flow but India ban hinders U.S. approval of hydroxychloroquine

›
The production of Chinese active pharmaceutical ingredients (APIs) slipped by 10% to 20% during the early days of the COVID-19 outbreak ...

Temperature check at Walmart

›
Walmart ( WMT +0.3% ) says it has decided to begin taking the temperatures of its associates as they report to work in stores, clubs an...